These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 4018873)
1. Marked enhancement in vivo of adjuvant activity of muramyl dipeptide to protein antigens and to synthetic weak immunogens with monoclonal anti-muramyl dipeptide antibodies. Bahr GM; Tello DS; Chedid LA Infect Immun; 1985 Aug; 49(2):312-9. PubMed ID: 4018873 [TBL] [Abstract][Full Text] [Related]
2. Marked enhancement of macrophage activation induced by synthetic muramyl dipeptide (MDP) conjugate using monoclonal anti-MDP antibodies. Leclerc C; Bahr GM; Chedid L Cell Immunol; 1984 Jul; 86(2):269-77. PubMed ID: 6733783 [TBL] [Abstract][Full Text] [Related]
3. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine. Heymer B; Finger H; Wirsing CH Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536 [TBL] [Abstract][Full Text] [Related]
4. Preparation for hapten help by glucan, muramyl dipeptide, and its L-ala-Glycerol-mycolate derivative. Leech SH; Di Luzio NR; Leclerc C J Leukoc Biol; 1985 Aug; 38(2):317-25. PubMed ID: 3861748 [TBL] [Abstract][Full Text] [Related]
5. Effect of a synthetic adjuvant on the induction of primary immune responses in T cell-depleted spleen cultures. Watson J; Whitlock C J Immunol; 1978 Jul; 121(1):383-9. PubMed ID: 307582 [TBL] [Abstract][Full Text] [Related]
6. The muramyl dipeptide analog GMTP-N-DPG preferentially induces cellular immunity to soluble antigens. Fast DJ; Vosika GJ Vaccine; 1997 Nov; 15(16):1748-52. PubMed ID: 9364678 [TBL] [Abstract][Full Text] [Related]
7. Study of immunomodulatory properties of N-acetylmuramyl-L-alanyl-D-isoglutamine and N-acetylglucosaminyl-(beta 1----4)-N-acetylmuramyl-L-alanyl-D-isoglutamine. Dozmorov IM; Kuzin II; Lutsan NI; Lutsenko GV; Prokhorova AL; Sapozhnikov AM; Andronova TM; Ivanov VT Biomed Sci; 1991; 2(6):651-8. PubMed ID: 1841635 [TBL] [Abstract][Full Text] [Related]
8. Detection of antibodies to muramyl dipeptide, the adjuvant moiety of streptococcal cell wall, in patients with rheumatic fever. Bahr GM; Majeed HA; Yousof AM; Chedid L; Behbehani K J Infect Dis; 1986 Dec; 154(6):1012-7. PubMed ID: 3782865 [TBL] [Abstract][Full Text] [Related]
9. Effects of muramyl dipeptide treatment on resistance to infection with Toxoplasma gondii in mice. Krahenbuhl JL; Sharma SD; Ferraresi RW; Remington JS Infect Immun; 1981 Feb; 31(2):716-22. PubMed ID: 7216470 [TBL] [Abstract][Full Text] [Related]
10. Enhancement by murabutide of the immune response to natural and synthetic hepatitis B surface antigens. Audibert FM; Przewlocki G; Leclerc CD; Jolivet ME; Gras-Masse HS; Tartar AL; Chedid LA Infect Immun; 1984 Jul; 45(1):261-6. PubMed ID: 6735468 [TBL] [Abstract][Full Text] [Related]
11. Persistent enhancement of cell-mediated and antibody immune responses after administration of muramyl dipeptide derivatives with antigen in metabolizable oil. Carelli C; Audibert F; Chedid L Infect Immun; 1981 Jul; 33(1):312-4. PubMed ID: 7263069 [TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies to the synthetic adjuvant muramyl dipeptide: characterization of the specificity. Bahr GM; Eshhar Z; Ben-Yitzhak R; Modabber FZ; Arnon R; Sela M; Chedid L Mol Immunol; 1983 Jul; 20(7):745-52. PubMed ID: 6888382 [TBL] [Abstract][Full Text] [Related]
13. [Muramyl dipeptide and its synthetic analog as possible inducers of interleukin-2 production]. Malaĭtsev VV; Bogdanov IM; Sukhikh GT; Andronova TM Biull Eksp Biol Med; 1985 Aug; 100(8):221-3. PubMed ID: 3875372 [TBL] [Abstract][Full Text] [Related]
15. Synthetic low-toxicity muramyl dipeptide and monophosphoryl lipid A replace Freund complete adjuvant in inducing growth-inhibitory antibodies to the Plasmodium falciparum major merozoite surface protein, gp195. Hui GS; Tam LQ; Chang SP; Case SE; Hashiro C; Siddiqui WA; Shiba T; Kusumoto S; Kotani S Infect Immun; 1991 May; 59(5):1585-91. PubMed ID: 2019429 [TBL] [Abstract][Full Text] [Related]
16. Stimulation of the in vivo dinitrophenyl antibody response to the DNP conjugate of L-glutamic acid60-L-alanine30-L-Tyrosine10 (GAT) polymer by a synthetic adjuvant, muramyl dipeptide (MDP): target cells for adjuvant activity and isotypic pattern of MDP-stimulated response. Lowy I; Theze J; Chedid L J Immunol; 1980 Jan; 124(1):100-4. PubMed ID: 6965289 [TBL] [Abstract][Full Text] [Related]
17. Activation of mouse peritoneal adherent cells with N-acyl muramyl dipeptide derivatives. Nishimura K; Okumura H; Saiki I; Okuyama H; Azuma I Infect Immun; 1985 Mar; 47(3):665-9. PubMed ID: 3882562 [TBL] [Abstract][Full Text] [Related]
18. [Use of muramyl dipeptides in models of synthetic vaccines]. Audibert F Boll Ist Sieroter Milan; 1985; 64(2):95-102. PubMed ID: 3896261 [TBL] [Abstract][Full Text] [Related]
19. Well-defined and potent liposomal hepatitis B vaccines adjuvanted with lipophilic MDP derivatives. Jain V; Vyas SP; Kohli DV Nanomedicine; 2009 Sep; 5(3):334-44. PubMed ID: 19523433 [TBL] [Abstract][Full Text] [Related]